Scarica l'app Stockscreener
1.21
1.63%
-0.02
Precedente Chiudi:
$1.23
Aprire:
$1.23
Volume 24 ore:
11,216
Relative Volume:
0.10
Capitalizzazione di mercato:
$18.89M
Reddito:
$52.16M
Utile/perdita netta:
$-48.60M
Rapporto P/E:
-0.2801
EPS:
-4.32
Flusso di cassa netto:
$-77.48M
1 W Prestazione:
-3.20%
1M Prestazione:
-23.42%
6M Prestazione:
-34.95%
1 anno Prestazione:
-79.11%
Intervallo 1D:
$1.20
$1.27
Intervallo di 1 settimana:
$1.1725
$1.35
Portata 52W:
$0.721
$6.77
Hookipa Pharma Inc Stock (HOOK) Company Profile
Nome
Hookipa Pharma Inc
Settore
Industria
Telefono
0114318906360
Indirizzo
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
Confronta HOOK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
1.23 | 18.89M | 52.16M | -48.60M | -77.48M | -4.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-15 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-12-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-11-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-08 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-03 | Iniziato | Truist | Buy |
| 2020-10-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-10-19 | Ripresa | H.C. Wainwright | Buy |
| 2019-09-27 | Iniziato | H.C. Wainwright | Buy |
| 2019-05-13 | Iniziato | BofA/Merrill | Buy |
| 2019-05-13 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Hookipa Pharma Inc Borsa (HOOK) Ultime notizie
Millennium Management LLC Purchases Shares of 15,326 Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
Squarepoint Ops LLC Takes $104,000 Position in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
Gilead to buy certain Hookipa Pharma assets for up to $10M - MSN
Gilead (GILD) to Acquire HOOK for $10 million - MSN
Gilead Sciences to Acquire HOOKIPA Pharma Assets for $10M - GuruFocus
Hookipa Pharma (NASDAQ:HOOK) Trading Up 6.6% – Time to Buy? - Defense World
HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise - marketscreener.com
Hookipa stock gains as Gilead eyes assets (HOOK:NASDAQ) - Seeking Alpha
Poolbeg Pharma plc (AIM:POLB) Increase of BookBuild Offer - Share Talk
HOOKIPA Pharma Inc expected to post a loss of $1.04 a shareEarnings Preview - TradingView
The Significance of Moving Averages in Hookipa Pharma Inc Inc. (HOOK) Price Performance - investchronicle.com
Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - Defense World
Short Interest in Hookipa Pharma Inc (NASDAQ:HOOK) Drops By 75.2% - The AM Reporter
Hookipa Pharma stock hits 52-week low at $0.81 amid sharp decline - Investing.com India
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline By Investing.com - Investing.com South Africa
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India
Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday - Defense World
HOOKIPA Pharma to participate in upcoming investor conferences in September - marketscreener.com
Hookipa Pharma (HOOK) Expected to Announce Earnings on Thursday - Defense World
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com Australia
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline By Investing.com - Investing.com South Africa
HOOKIPA Pharma Inc. SEC 10-K Report - TradingView
Hookipa Pharma stock hits 52-week low at $1.71 amid downturn - MSN
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn By Investing.com - Investing.com South Africa
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN
BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
Poolbeg slumps as Hookipa merger is called off - pharmaphorum
Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World
Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk
Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors USA
Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewswire
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma - Investing.com India
Failed Merger: Why HOOKIPA Pharma Walked Away from Poolbeg Deal - StockTitan
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - Yahoo Finance
Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings - Defense World
HOOKIPA completes enrollment for HIV vaccine trial By Investing.com - Investing.com Nigeria
Hookipa Pharma Inc Azioni (HOOK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
7.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):